SCHEMBL8790636

SCHEMBL8790636

CC(=O)On1nnnc1-c1sccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
KMT2A Q03164 4/20 0.42
TSHR P16473 3/20 0.40
ACLY P53396 2/20 0.39
LMNA P02545 3/20 0.39
HPGD P15428 1/20 0.39
METAP2 P50579 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
GAA P10253 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 1/20 0.38
CYP2C9 P11712 2/20 0.38
MEN1 O00255 1/20 0.38
AGTR1 P30556 1/20 0.38
GLO1 Q04760 1/20 0.38
PAX8 Q06710 1/20 0.38
SLC40A1 Q9NP59 1/20 0.38
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8791028 0.88 KMT2A (0.32) CA2CA9KMT2ATSHRLMNA
SCHEMBL8791619 0.80 ALDH1A1 (0.42) CA2CA9KMT2ATSHRLMNA
SCHEMBL8791221 0.80 PIK3C3 (0.36) HPGDGAAALDH1A1KDM4E
SCHEMBL8791633 0.76 CYP2A6 (0.38) KMT2ATSHRLMNAHPGDALDH1A1
SCHEMBL8791391 0.76 RAB9A (0.46) KMT2ATSHRALDH1A1HTTCYP2C9
SCHEMBL8791593 0.73 HSD11B1 (0.36) KMT2ATSHRLMNAHPGDGAA
SCHEMBL8792325 0.71 MAPK8 (0.33) ALDH1A1
SCHEMBL9568787 0.70 HSD11B1 (0.46) KMT2ATSHRLMNAALDH1A1HTT
SCHEMBL8790766 0.70 KMT2A (0.48) KMT2ATSHRHPGDGAAALDH1A1
SCHEMBL532975 0.69 ACLY (0.69) KMT2ATSHRACLYLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421365-B1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity WAKAMOTO PHARMA CO LTD (JP) 1997-03-05 EP disclosed
US-RE35321-E ANTIDIABETIC AGENT WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-08-27 US disclosed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US disclosed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP disclosed